跳至主要内容
临床试验/NCT03838874
NCT03838874已完成2 期

Double Blind Randomized Clinical Trial Comparing Time To Return of Lower Extremity Motor Function Following Spinal Anesthetic With Mepivacaine Versus Low-Dose Bupivacaine For Primary Total Hip and Knee Arthroplasty

Mayo Clinic1 个研究点 分布在 1 个国家目标入组 154 人开始时间: 2019年2月25日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
发起方
Mayo Clinic
入组人数
154
试验地点
1
主要终点
Time to Return of Lower Extremity Motor Function

研究概览

简要总结

This research is being done to see if there is a difference between two different spinal anesthetics (Mepivacaine vs. Bupivacaine) as it relates to reducing post-operative complications and the time it takes for subjects to regain mobility after surgery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Days 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • American Society of Anesthesiologists (ASA) physiological status I-III (patient must meet criteria of a status I-III in the ASA Physical Status Classification System: I=Normal Healthy Patient, II=Mild Systemic Disease, and III=Severe Systemic Disease)
  • Unilateral primary TKA or THA
  • 18+ years of age
  • Able to provide informed consent

排除标准

  • Chronic pain syndromes such as fibromyalgia or complex regional pain syndrome
  • Chronic opioid use (>1 mos) with OME >5 mg/day OR acute opioid use (< 1 mos) with OME > 30 mg/day.
  • Body mass index (BMI) > 45 kg/m2
  • Severe drug allergy* to medications used in this study, including non-steroidal anti-inflammatory drugs (i.e. celecoxib and ketorolac), and local anesthetics (defined as an immune reaction resulting in shortness of breath, hives, anaphylaxis, wheezing, and fever)
  • Major systemic medical comorbidities such as:
  • Pre-existing severe renal disorder defined as glomerular filtration rate (GFR) <50 units/m2 (if labs are available), currently on dialysis, or highly suspected based on history.
  • Severe hepatic disorder defined as current or past diagnosis of acute/subacute necrosis of liver, acute hepatic failure, chronic liver disease, cirrhosis (primary biliary cirrhosis), chronic hepatitis/toxic hepatitis, liver abscess, hepatic coma, hepatorenal syndrome, other disorders of liver
  • Contraindication to spinal anesthesia technique (e.g., known spinal stenosis, coagulopathy, sepsis, infection at site of injection, uncooperative, refusal, anticoagulation medications not held within appropriate time frame*). *Per ASRA guidelines, Clopidogrel (Plavix) held for at least 7 days, Dabigatran (Pradexa) held for at least 5 days, Rivaroxaban (Xarelto)held for at least 3 days, Warfarin (Coumadin)held for at least 5 days or recent INR of less than 1.4, Enoxaparin (Lovenox) with doses > 1 mg/kg held for close to 24 hours.
  • Known to be currently pregnant or actively breastfeeding. Patients that have a previous history of menopause, hysterectomy, or tubal ligation will not be required to perform a pregnancy test. Female patients that do not meet this criterion will be asked to submit a urine sample, and will require a negative urine sample in order to proceed with study protocol. Urine sample be collected pre-procedurally.
  • Impaired cognition

研究组 & 干预措施

Low-Dose Bupivacaine

Active Comparator

Subjects in this group will be given 10mg of Low-Dose Bupivacaine, which is within standard of care for spinal anesthesia during TKA or THA.

干预措施: Low-Dose Bupivacaine (Drug)

Mepivacaine

Active Comparator

Subjects in this group will be given 70mg of Mepivacaine, which is within standard of care for spinal anesthesia during TKA or THA.

干预措施: Mepivacaine (Drug)

结局指标

主要结局

Time to Return of Lower Extremity Motor Function

时间窗: Post surgery, approximately 1 day

Assessed by measuring time from spinal anesthetic administration to postoperative achievement of Bromage 0 function (return of spontaneous ankle, knee, and hip movement) in the non-operative extremity at 15-minute intervals.

次要结局

  • Post-Anesthesia Care Unit (PACU) Length of Stay(Time of discharge, approximately 1-2 days)
  • Discharge Pain Score(Time of discharge, approximately 1-2 days)
  • Hospital Length of Stay(Time of discharge, approximately 1-2 days)
  • Maximum Pain Score(24 hours following the surgical procedure)
  • Median Pain Score(24 hours following the surgical procedure)
  • Urinary Retention(Time of discharge, approximately 1-2 days)
  • Transient Neurologic Symptoms(One week post-operative)
  • Orthostatic Hypotension(Time of discharge, approximately 1-2 days)

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Principal Investigator
主要研究者

Matthew P. Abdel, M.D.

Principal Investigator

Mayo Clinic

研究点 (1)

Loading locations...

相似试验